318 filings
Page 4 of 16
8-K
kfy0ogvpkl63c
14 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
b6ov8i cgwk4s
19 Jun 17
Entry into a Material Definitive Agreement
12:00am
424B5
dp7bt nz5q
19 Jun 17
Prospectus supplement for primary offering
12:00am
424B5
bo50k4xvt5b9eahh9u
19 Jun 17
Prospectus supplement for primary offering
12:00am
AW WD
wltsm8gns1z
9 Jun 17
Withdrawal of amendment withdrawal request
12:00am
S-8 POS
bgp5b
9 Jun 17
Registration of securities for employees (post-effective amendment)
12:00am
AW
ty6786ptmozg2q4
9 Jun 17
Withdrawal of amendment
12:00am
AW
rm52iujidn j1sp
8 Jun 17
Withdrawal of amendment
12:00am
POS AM
71by01v hzd
5 Jun 17
Prospectus update (post-effective amendment)
12:00am
S-8
yezm35pc0 eswe
1 Jun 17
Registration of securities for employees
12:00am
8-K
cifmj5yvs6
25 May 17
Other Events
12:00am
8-K
xe7ho54l5t u08zcrerd
18 May 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
av5idm5tlys
10 May 17
Anthera Pharmaceuticals Provides Business Update
12:00am
8-K
9seusz38ba8qw93 q8
28 Apr 17
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
12:00am
8-K
rjjt6f4pns7zlu5b
27 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
gno1e
31 Mar 17
Anthera Announces Positive Results from the Extension Period of the SOLUTION Study of Sollpura
12:00am
DEFA14A
h4ww 5avtxp4
16 Mar 17
Additional proxy soliciting materials
12:00am